1. Rafique S, Sterling EW, Nelson LM. A new approach to primary ovarian insufficiency. Obstet Gynecol Clin North Am 2012;39:567-586.
2. Cox L, Liu JH. Primary ovarian insufficiency: an update. Int J Womens Health 2014;235.243.
3. Torrealday S, Kodaman P, Pal L. Premature ovarian insufficiency - an update on recent advances in understanding and management. F1000Res 2017;6:2069.
4. Fenton AJ. Premature ovarian insufficiency: Pathogenesis and management. J Midlife Health 2015;6:147-153.
5. Grynnerup AGA, Lindhard A, Sorensen S. The role of anti-Müllerian hormone in female fertility and infertility - an overview. Acta Obstet Gynecol Scand 2012;91:1252-1260.
6. Kruszyńska A, Słowińska-Srzednicka J. Anti-Müllerian hormone (AMH) as a good predictor of time of menopause. Prz Menopauzalny 2017;16:47-50.
7. Visser JA, Schipper I, Laven JSE, Themmen A. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol 2012;8:331-341.
8. Knauff EAH, Eijkemans MJC, Lambalk CB, Ten Kate-Booij MJ, Hoek A, Beerendonk CCM, Themmen AP, de Jong FH, Fauser BC. Anti-Müllerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. J Clin Endocrinol Metab 2009;94:786-792.
9. La Marca A, Brozzetti A, Sighinolfi G, Marzotti S, Volpe A, Falorni A. Primary ovarian insufficiency: autoimmune causes. Curr Opin Obstet Gynecol 2010;22:277-282.
10. Usta T, Oral E. Is the measurement of anti-Müllerian hormone essential? Curr Opin Obstet Gynecol 2012;24:151-157.
11. Peluso C, Fonseca FLA, Gastaldo GG, Christofolini DM, Cordts EB, Barbosa CP, Bianco B. AMH and AMHR2 polymorphisms and AMH serum level can predict assisted reproduction outcomes: A cross-sectional study. Cell Physiol Biochem 2015;35:1401-1412.
12. Jurczak A, Szkup M, Grzywacz A, Safranow K, Grochans E. The relationship between AMH and AMHR2 polymorphisms and the follicular phase in late reproductive stage women. Int J Environ Res Public Health 2016;13:185.
13. Kevenaar ME, Themmen APN, Laven JSE, Sonntag B, Fong SL, Uitterlinden AG, de Jong FH, Pols HA, Simoni M, Visser JA. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women. Hum Reprod 2007;22:1547-1554.
14. Karagiorga I, Partsinevelos GA, Mavrogianni D, Anagnostou E, Zervomanolakis I, Kallianidis K,
Drakakis P,
Loutrdis D. Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile49Ser) and Anti-Müllerian hormone type II receptor (AMHRII −482 A>G) as genetic markers in assisted reproduction technology. J Assist Reprod Genet 2015;32:357-367.
15. Greiber IK, Hagen CP, Busch AS, Mieritz MG, Aksglæde L, Main K, Almstrup K, Juul A. The AMH genotype (rs10407022 T> G) is associated with circulating AMH levels in boys, but not in girls. Endocr Connect 2018;7:347-354.
16. Čuš M, Vlaisavljević V, Repnik K, Potočnik U, Kovačič B. Could polymorphisms of some hormonal receptor genes, involved in folliculogenesis help in predicting patient response to controlled ovarian stimulation. J Assist Reprod Genet 2019;36:47-55.